CDKN2A and Treacher-Collins syndrome: The results of our study confirm that TCS develop an immunosenescent profile, evidenced by an altered pattern of peripheral lymphocyte subpopulations, and elevated expression of the aging biomarker CDKN2A/p16INK4a.